Berberine ursodeoxycholate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Berberine ursodeoxycholate (HTD1801) 是 Berberine 和 Ursodeoxycholic acid 的一种离子盐，是一种口服有效的降血脂剂 (hypolipidemic agent)。Berberine ursodeoxycholate 能显著降低肝脏脂肪含量。Berberine ursodeoxycholate 具有广泛的代谢活性。Berberine ursodeoxycholate 可用于高脂血症、非酒精性脂肪性肝炎 (NASH) 和糖尿病的研究。

Berberine ursodeoxycholate (HTD1801), an ionic salt of Berberine and Ursodeoxycholic acid, is an orally active and potent hypolipidemic agent. Berberine ursodeoxycholate shows significantly great reduction in liver fat content. Berberine ursodeoxycholate has a broad spectrum of metabolic activity. Berberine ursodeoxycholate can be used for the research of hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes.

——

Berberine ursodeoxycholate shows significant reductions in HbA1c (hemoglobin A1c) levels, mean HbA1c levels decreases by 0.6%.Berberine ursodeoxycholate is ingested in the form of a salt and it is thought that the salt promptly dissociates within the gastrointestinal tract and that Berberine and Ursodeoxycholic acid are differentially absorbed.

——

Others

Other Targets

Others

——

——

1868138-66-2

217.69

C6H8CuN3O2

>98% (HPLC)

In Vitro:?DMSO 中的溶解度 : 5 mg/mL (6.87 mM; 超声助溶 (<60°C)

COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC.[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC([O-])=O

——

(-20℃)

With Ice Pack

≥ 2 years